Clinical results of photodynamic therapy for superficial skin malignancies or actinic keratosis using topical 5-aminolaevulinic acid

Lasers in Medical Science

Volumn 11, Issue 2, 1996, Pages 123-131

  Meijnders, P J N ^a   Star, W M ^a   De Bruijn, R S ^a   Treurniet Donker, A D ^a   Van Mierlo, M J M ^a   Wijthoff, S J M ^a   Naafs, B ^a   Beerman, H ^a   Levendag, P C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

5 aminolaevulinic acid; Actinic keratosis; Basal cell carcinoma; Photodynamic therapy; Protoporphyrin IX; Skin neoplasms

Indexed keywords

AMINOLEVULINIC ACID;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE; FOLLOW UP; HUMAN; ILLUMINATION; MALE; NEVUS; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN CANCER; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; WOUND HEALING;

EID: 0029955422     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02133209     Document Type: Article

References (38)

1. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992, 327:1649-62
2. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in the photoactivation of a murine tumour. Cancer Res 1976, 36:2326-9
3. Wilson BD, Mang TS, Stoll H et al. Photodynamic therapy for the treatment of basal cell carcinoma Arch Dermatol 1992, 128:1597-1601
4. Buscaglia DA, Shanler SD, Mang TS et al. Photodynamic therapy with Photofrm II successfully treats basal cell carcinomas in patients with basal cell nevus syndrome. J Invest Dermatol 1994, 102:615
5. Robinson PJ, Carruth JAS, Fairris GM. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br J Dermatol 1988, 119:59-61
6. Jones CM, Mang T, Cooper M et al. Photodynamic therapy in the treatment of Bowen's disease. J Am Acad Dermatol 1992, 27:979-82
7. Razum N, Balchum OJ, Profio AE et al. Skin photosensivity: duration and intensity following intravenous hematoporphyrin derivatives, HpD and DHE. Photochem Photobiol 1987, 46:925-8
8. Dougherty TJ, Cooper MT, Mang TS. Cutaneous phototoxic occurrences in patients receiving photofrin. Lasers Surg Med 1990, 10:485-8
9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B: Biology 1990, 6:143-8
10. Divaris DXG, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. Am J Pathol 1990, 136:891-7
11. Pottier RH, Chow YFA, LaPlante JP et al. Noninvasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem Photobiol 1986, 44:679-87
12. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B: Biology 1992, 14:275-92
13. Star WM, Versteeg AAC, Van Putten WLJ, Marijnissen JPA. Wavelength dependence of hematoporphyrin derivative photodynamic treatment effects on rat ears. Photochem Photobiol 1990, 52:547-54
14. Star WM. In vivo action spectra, absorption and fluorescence excitation spectra of photosensitizers for photodynamic therapy. J Photochem Photobiol B: Biology 1995, 28:101-2
15. Gijsbers GHM, Breederveld D, Van Gemert MJC et al. In vivo fluorescence excitation and emission spectra of hematoporphyrin derivative. Lasers Life Sci 1987, 1:29-48
16. Grant WE, Hopper C, MacRobert AJ et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 1993, 342:147-8
17. Loh CS, MacRobert AJ, Bedwell J et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 1993, 68:41-51
18. Szeimies RM, Abels C, Fritsch C et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 1995, 105:672-7
19. Elton RF. Cryosurgical advances and difficult cancers of the skin. In: Zacarion SA (ed) Cryosurgical Advances in Dermatology and Tumors of the Head and Neck. Springfield, Ill.: CC Thomas, 1977:150-70
20. Torre D. Cryosurgery in cancer. In: Andrade R (ed) Cancer of the Skin. Philadelphia: WB Saunders, 1976:1583-4
21. Menn H, Robins P, Kopf AW et al. The recurrent basal cell epithelioma. A study of 100 cases of recurrent, re-treated basal cell epitheliomas. Arch Dermatol 1971, 103:628-31
22. Sakura CY, Calamel PM. Comparison of treatment modalities for recurrent basal cell carcinoma. Plast Reconstr Surg 1979, 63:492-6
23. Hauben DJ. The biologic behaviour of basal cell carcinoma: analysis of recurrence in excised basal cell carcinoma. Plast Reconstr Surg 1982, 69:103-16
24. Scholten AN, Griep C, Davelaar J et al. Electron beam therapy is effective in the treatment of skin carcinoma; a comparison with superficial X-ray therapy. Ned Tijdschr Geneeskd 1996, 140(8):428-31
25. Cairnduff F, Stringer MR, Hudson EJ et al. Superficial photodynamic therapy with topical 5-ammolaevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 1994, 69:605-8
26. Calzavara Pinton PG. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B: Biology 1995, 29:53-7
27. Orenstein A, Kostenich G, Tsur H et al. Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, DMSO and EDTA. In: Brault D, Jori G, Moan J, Ehrenberg B (eds) Photodynamic Therapy of Cancer II. Proceedings of SPIE 1995, 2325:100-5
28. Svanberg K, Andersson T, Killander D et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation. Br J Dermatol 1994, 130:743-51
29. Warloe T, Peng Q, Heyerdahl H et al. Photodynamic therapy with 5-aminolevulinic acid induced porphyrins and DMSO/EDTA for basal cell carcinoma. In: Cortese DA (ed) Fifth International Photodynamic Association Biennial Meeting. Proceedings of SPIE 1995, 2371: 226-35
30. Szeimies RM, Sassy T, Landthaler M. Penetration potency of topical applied delta-aminolevulinic acid for photodynamic therapy of basal cell carcinoma. Photochem Photobiol 1994, 59:73-6
31. Peng Q, Warloe T, Moan J et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 1995, 62:906-13
32. Fijan S, Hönigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamme. Br J Dermatol 1995, 133:282-8
33. Lui H, Salasche S, Kollias N et al. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. Arch Dermatol 1995, 131:737-8
34. Messman H, Mlkvy P, Buonaccorsi G et al. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer 1995, 72:589-94
35. Hua Z, Gibson SL, Foster TH et al. Effectiveness of 6-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 1995, 55:1723-31
36. Van der Veen N. Van Leengoed HLLM, Star WM. In vivo fluorescence kinetics and photodynamic therapy using ALA-induced porphyrin: increased damage after multiple irradiations. Br J Cancer 1994, 70:867-72
37. Shanler SD, Buscaglia DA, Van Leengoed E et al. PDT with topical 8-aminolevulinic acid for treatment of patch and plaque stage cutaneous T-cell lymphoma. J Invest Dermatol 1994, 102:615
38. Wolf P, Fink-Puches R, Cerroni L et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1994, 31:678-80